119 related articles for article (PubMed ID: 7706698)
21. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?
Tziakas DN; Kaski JC; Chalikias GK; Romero C; Fredericks S; Tentes IK; Kortsaris AX; Hatseras DI; Holt DW
J Am Coll Cardiol; 2007 May; 49(21):2081-9. PubMed ID: 17531656
[TBL] [Abstract][Full Text] [Related]
22. The rate of transbilayer movement of erythrocyte membrane cholesterol is correlated with sodium-lithium countertransport.
Muriana FJ; Montilla C; Stiefel P; Villar J; Ruíz-Gutiérrez V
Life Sci; 1996; 59(23):1945-9. PubMed ID: 8950293
[TBL] [Abstract][Full Text] [Related]
23. Erythrocyte osmotic fragility in hypertension and during diuretic therapy.
Fasanmade AA
West Afr J Med; 1999; 18(3):183-6. PubMed ID: 10593154
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men.
Tsuda K
Obesity (Silver Spring); 2006 Sep; 14(9):1505-10. PubMed ID: 17030960
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease.
Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Chatzikyriakou SV; Mitrousi K; Kortsaris AX; Boudoulas H; Kaski JC
Coron Artery Dis; 2008 Dec; 19(8):583-90. PubMed ID: 19005293
[TBL] [Abstract][Full Text] [Related]
26. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters].
Caballero Oliver A; Stiefel García-Junco P; García-Donas López MA; Villar Ortiz J; Carneado de la Fuente J
Med Clin (Barc); 1995 Dec; 105(20):768-73. PubMed ID: 8558976
[TBL] [Abstract][Full Text] [Related]
27. Endothelial progenitor cells in patients with essential hypertension.
Delva P; Degan M; Vallerio P; Arosio E; Minuz P; Amen G; Di Chio M; Lechi A
J Hypertens; 2007 Jan; 25(1):127-32. PubMed ID: 17143183
[TBL] [Abstract][Full Text] [Related]
28. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Díez J; Laviades C
J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
[TBL] [Abstract][Full Text] [Related]
30. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
[TBL] [Abstract][Full Text] [Related]
31. Altered levels of erythrocyte calcium-binding proteins in essential hypertensives with genetic predisposition: correlation with ambulatory blood pressure.
Hojo Y; Ebata H; Kawasaki K; Tsuruya Y; Ikeda U; Nishinaga M; Natsume T; Ishida H; Shimada K
J Hypertens; 1994 Apr; 12(4):429-37. PubMed ID: 8064167
[TBL] [Abstract][Full Text] [Related]
32. [The relationship between insulin resistance and abnormalities of cellular calcium metabolism and cell membrane abnormalities in patients with essential hypertension].
Fu Y; Wang S; Lu Z
Zhonghua Yi Xue Za Zhi; 1997 Jun; 77(6):443-6. PubMed ID: 9772510
[TBL] [Abstract][Full Text] [Related]
33. [The erythrocyte membrane structure in patients with mixed hyperlipidemia].
Broncel M; Balcerak M; Bała A; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(1-2):4-9. PubMed ID: 17607961
[TBL] [Abstract][Full Text] [Related]
34. The relationship between inflammation and arterial stiffness in patients with essential hypertension.
Kampus P; Muda P; Kals J; Ristimäe T; Fischer K; Teesalu R; Zilmer M
Int J Cardiol; 2006 Sep; 112(1):46-51. PubMed ID: 16297996
[TBL] [Abstract][Full Text] [Related]
35. [Mechanical resistance of erythrocytes in hypertension].
Dudaev VA; Al'-Mubarak M
Sov Med; 1990; (2):10-1. PubMed ID: 2356509
[TBL] [Abstract][Full Text] [Related]
36. Comparison of calcium, magnesium-ATPase activity and membrane fluidity in patients with essential hypertension and in normotensive controls.
Miller MA; Sagnella GA; Markandu ND; MacGregor GA
J Hypertens; 1994 Aug; 12(8):929-38. PubMed ID: 7814852
[TBL] [Abstract][Full Text] [Related]
37. Relation of cholesterol esterification rate to the plasma distribution of high-density lipoprotein subclasses in normal and hypertensive women.
Dobiásová M; Stríbrná J; Frohlich JJ
Clin Invest Med; 1995 Dec; 18(6):449-54. PubMed ID: 8714788
[TBL] [Abstract][Full Text] [Related]
38. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
[TBL] [Abstract][Full Text] [Related]
39. [The lipid metabolic indices in hypertensive patients under a plant fat load].
Medvedeva IV
Vopr Pitan; 1992; (5-6):10-2. PubMed ID: 1296354
[No Abstract] [Full Text] [Related]
40. [Effect of cholesterol on the stability of human erythrocyte membranes to electric breakdown].
Goncharenko MS; Katkov II
Biofizika; 1985; 30(3):441-5. PubMed ID: 4027273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
